Doktorgrader

Andrej Valkov. Molecular prognostic markers in soft tissue sarcomas. Sept 2012. Primary supervisor: Lill-Tove Busund

Thomas Kilvær.  Angiogenic markers as prognostic factors in soft tissue sarcomas. May 2012. Primary supervisor: Tom Dønnem

Sigve Andersen. Hypoxic markers and prognosis in non-small cell lung cancer (NSCLC). Nov 2011. Primary supervisor: Roy M. Bremnes

Khalid Al-Shibli. The prognostic significance of the innate and adaptive immune system in non-small cell lung carcinoma. May 2010. Primary supervisor: Lill-Tove Busund

Samer Al-Saad. Prognostic impact of molecular markers related to tumor differentiation and proliferation in non-small cell lung cancer. April 2010. Primary supervisor: Lill-Tove Busund

Bjørn-Henning Grønberg. Pemetrexed in the treatment of advanced lung cancer. March 2010. Co-supervisor: Roy M. Bremnes

Hege Sagstuen. Cardiovascular risk factors and pulmonary function in long-term survivors of testicular cancer. April 2009. Primary supervisor: Roy M. Bremnes

Tom Dønnem. Molecular analysis of angiogenic markers as prognostic factors for non-small cell lung cancer (NSCLC) – A new translational research strategy involving tissue microarray technology at the University Hospital North Norway and the University of Tromsø. March 2009. Primary supervisor: Roy M. Bremnes

Nina Helbekkmo. Advances non-small cell lung cancer. Effects of chemotherapy and impacts on health related quality of life. March 2009. Primary supervisor: Roy M. Bremnes.

Elin Richardsen. Prognostic molecules in hormone-sentive carcinomas with special focus on prostate cancer.  April 2008 Primary supervisor: Lill-Tove Busund